Skip to main content

Table 2 Frequency and association of patient demographics, clinical characteristics and underlying disease severity with HRG at the time of presentation of IE patients admitted at AKUH 2015–2017 (n = 36)

From: Microbiological and clinical profile of infective endocarditis patients: an observational study experience from tertiary care center Karachi Pakistan

PATIENT CHARACTERISTICS

HRG N = 14

NVG N = 22

p-value

Odds Ratio (Confidence interval)

Mean Age

45

38

Gender: Male

8

15

0.501

0.838 (0.490–1.432)

MoDC

Definite

12

16

0.361

1.179 (0.844–1.645)

Probable

2

6

0.361

0.524 (0.122–2.240)

Acute clinical presentation

5

12

0.270

0.655 (0.294–1.457)

Sub-acute presentation

9

10

0.270

1.414 (0.775–2.581)

Positive culture

10

20

0.126

0.786 (0.550–1.122)

Pure culture growth

14

18

0.091

1.222 (1.004–1.488)

Rheumatic heart disease

0

4

0.090

 

Prosthetic heart valve / cardiac implants

11

0

Congenital heart disease

6

5

0.201

1.886 (0.708–5.022)

Severity at presentation

 Signs of thromboembolisma

2

7

0.236

0.449(0.108–1.860)

 Sepsis

1

6

0.137

0.262 (0.951–1.714)

 Multi organ dysfunction

4

7

0.837

0.898 (0.321–2.514)

 Rash /splinter hemorrhage

0

4

0.091

Previous history of infective endocarditis

1

0

0.204

Murmur

2

8

0.149

0.393 (0.920–1.972)

Raised infectious markers

1

2

0.837

0.786 (0.078–7.876)

Radiologic evidence on Echocardiography

    

Vegetation

13

14

0.048

1.45 (1.03–2.066)

Mitral valve prolapse

0

3

0.149

Peri-annular abscess

2

3

0.956

1.048 (0.199–5.504)

Valve perforation / dehiscence

1

1

0.740

1.571 (0.107–23.140)

Portal hypertension

8

11

0.826

Aortic regurgitation

6

10

0.878

0.943 (0.442–2.013)

Mitral regurgitation

4

7

0.837

0.898 (0.321–2.514)

Pulmonary regurgitation

2

0

0.068a

  1. HRG High risk group, NVG Native valve group, MoDC Modified Dukes Criteria
  2. a= gangrene, unilateral weakness, slurring of speech, loss of consciousness